Effect of routine versus selective protamine administration on bleeding in patients undergoing transcatheter aortic valve implantatio

Phase 4

Completed

• Conditions: aortic stenosis; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12621001261808
• Lead Sponsor: Antony Walton

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-09-17
• Study Completion: 2023-07-01
• Last Update Posted: 6 November 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 410

Inclusion Criteria

Participants eligible for inclusion in this study are:
- aged 18 years or older.
- undergoing elective trans-femoral TAVI with any commercially available transcatheter heart valve.

Exclusion Criteria

Participants not eligible for inclusion in this study are:
- Documented protamine allergy or anaphylaxis
- Recent PCI (< 3 months)
- Planned arterial access via surgical cut-down
- Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified